EMBO Molecular Medicine is an open access online journal published by Wiley-Blackwell on behalf of EMBO. The quality of the journal is guaranteed by the editorial and advisory boards, consisting ...

Impact and progress Frontiers' impact Progress Report 2022 All progress reports ...

Modern medicine has entered the molecular era, demanding a deeper understanding, diagnosis, treatment, and prevention of major diseases at the molecular level. A comprehensive analysis of functional ...

Liver x receptors (LXRs) regulate lipid metabolism in response to changing cholesterol levels. Here, the authors show that inactivation of LXR signaling leads to the rapid development of metabolic ...

Impact and progress Frontiers' impact Progress Report 2022 All progress reports ...

Welcome to the Department of Molecular and Clinical Medicine. Here research and education about cardiovascular disease, obesity, diabetes, and metabolism, in particular, are under way. Our mission is, ...

The Department of Biochemistry and Molecular Pharmacology at NYU Langone Health has a rich and distinguished history and maintains active research programs in epigenetics, genome integrity, protein ...

Jan. 8, 2025 — Elderberry juice may be a potent tool for weight management and enhancing metabolic health, according to a recent study. A clinical trial found that drinking 12 ounces of ...

Jan. 30, 2025 — A research group has developed new advanced light-controlled tools that enable precise control of proteins in real time in living cells. This groundbreaking research opens doors ...

Submit here EMBO Molecular Medicine is dedicated to new research at the interface between clinical research and basic biology. Studies based on model organisms also fall within the scope of the ...

The paper investigates a potential cause of a type of severe epilepsy that develops in early life because of a defect in a gene called KCNQ2. The significance is fundamental because it substantially ...